Brief: Syros Reports Q2 Loss Of 54 Cents Per Share

Syros Pharmaceuticals

09/08/2022 12:34

Aug 9 (Reuters) - Syros Pharmaceuticals Inc  SYRS.O :
    * SYROS REPORTS SECOND QUARTER 2022 FINANCIAL RESULTS AND PROVIDES A
CORPORATE
UPDATE
    * Q2 LOSS PER SHARE $0.54
    * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES AS OF JUNE 30, 2022 WERE
$86.3
MILLION
    * QTRLY REVENUE $6.3 MILLION VERSUS  $5.2 MILLION
    * Q2 EARNINGS PER SHARE VIEW $-0.41, REVENUE VIEW $4.6 MILLION -- REFINITIV
IBES
DATA

Source text for Eikon:  ID:nBw8DB6dpa 
Further company coverage:  SYRS.O 

 ((Reuters.Briefs@thomsonreuters.com;))